Literature DB >> 19527210

First Australian isolation of epidemic Clostridium difficile PCR ribotype 027.

Thomas V Riley1, Sarah Thean, Graham Hool, Clayton L Golledge.   

Abstract

We report the first isolation in Australia of a hypervirulent epidemic strain of Clostridium difficile, PCR ribotype 027. It was isolated from a 43-year-old woman with a permanent ileostomy, who appears to have been infected while travelling in the United States. The isolate was positive for toxin A, toxin B and binary toxin, and resistant to fluoroquinolone antimicrobials, and had characteristic deletions in the tcdC gene. All diagnostic laboratories and health care facilities in Australia should now be on high alert for this organism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19527210     DOI: 10.5694/j.1326-5377.2009.tb02644.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  17 in total

1.  An enhanced DNA fingerprinting service to investigate potential Clostridium difficile infection case clusters sharing the same PCR ribotype.

Authors:  Warren N Fawley; Mark H Wilcox
Journal:  J Clin Microbiol       Date:  2011-09-28       Impact factor: 5.948

2.  Presumptive identification of Clostridium difficile strain 027/NAP1/BI on Cepheid Xpert: interpret with caution.

Authors:  Jen Kok; Qinning Wang; Lee C Thomas; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2011-08-17       Impact factor: 5.948

Review 3.  The changing epidemiology of Clostridium difficile infections.

Authors:  J Freeman; M P Bauer; S D Baines; J Corver; W N Fawley; B Goorhuis; E J Kuijper; M H Wilcox
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

4.  Underestimation of Clostridium difficile infection among clinicians: an international survey.

Authors:  M N Mavros; V G Alexiou; K Z Vardakas; K Tsokali; T A Sardi; M E Falagas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-03-27       Impact factor: 3.267

5.  Comparison of Clostridium difficile Ribotypes Circulating in Australian Hospitals and Communities.

Authors:  Luis Furuya-Kanamori; Thomas V Riley; David L Paterson; Niki F Foster; Charlotte A Huber; Stacey Hong; Tiffany Harris-Brown; Jenny Robson; Archie C A Clements
Journal:  J Clin Microbiol       Date:  2016-12-28       Impact factor: 5.948

6.  Epidemiology of Clostridium (Clostridioides) difficile Infection in Southeast Asia.

Authors:  Peng An Khun; Thomas V Riley
Journal:  Am J Trop Med Hyg       Date:  2022-08-08       Impact factor: 3.707

7.  Clostridium difficile as a cause of healthcare-associated diarrhoea among children in Auckland, New Zealand: clinical and molecular epidemiology.

Authors:  V Sathyendran; G N McAuliffe; T Swager; J T Freeman; S L Taylor; S A Roberts
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-09       Impact factor: 3.267

Review 8.  Clostridium difficile Infection.

Authors:  Jae Hyun Shin; Esteban Chaves-Olarte; Cirle A Warren
Journal:  Microbiol Spectr       Date:  2016-06

9.  Comparison of PCR ribotyping and multilocus variable-number tandem-repeat analysis (MLVA) for improved detection of Clostridium difficile.

Authors:  Hsiao L Wei; Chun Wei Kao; Sung H Wei; Jason T C Tzen; Chien S Chiou
Journal:  BMC Microbiol       Date:  2011-09-30       Impact factor: 3.605

10.  Prevalence of Clostridium difficile colonization among healthcare workers.

Authors:  N Deborah Friedman; James Pollard; Douglas Stupart; Daniel R Knight; Masoomeh Khajehnoori; Elise K Davey; Louise Parry; Thomas V Riley
Journal:  BMC Infect Dis       Date:  2013-10-04       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.